PRM55 A New Approach to Modeling Cancer Recurrence and Follow-Up by Rose, J, Augestad, K.M, Cooper, G, Meropol, N.J

Get full text

Patient-physician discordance in goals of care for patients with advanced cancer by Douglas, S L, Daly, B J, Meropol, N J, Lipson, A R

Get full text

The relationships among knowledge, self-efficacy, preparedness, decisional conflict, and decisions to participate in a cancer clinical trial by Miller, S. M., Hudson, S. V., Egleston, B. L., Manne, S., Buzaglo, J. S., Devarajan, K., Fleisher, L., Millard, J., Solarino, N., Trinastic, J., Meropol, N. J.

Get full text

Telomerase is Frequently Activated in Tumors with Microsatellite Instability by Caceres, I. Ibanez de, Frolova, N., Varkonyi, R.J., Dulaimi, E., Meropol, N.J., Broccoli, D., Cairns, P.

Get full text

Oral fluoropyrimidines in the treatment of colorectal cancer by Meropol, N.J

Get full text

3019 POSTER Association of gene copy number (GCN) of the epidermal growth factor receptor (EGFr) and clinical outcome in patients (pts) with metastatic colorectal cancer (mCRC) tre... by Berlin, J, Hecht, J.R, Reiner, M, Mullenix, M, Suggs, S, Radinsky, R, Freeman, D, Amado, R.G, Meropol, N.J

Get full text

3014 (Presidential session, Tue 25 Sep 12.30–14.30) ORAL Association of somatic KRAS gene mutations and clinical outcome in patients (pts) with metastatic colorectal cancer (mCRC)... by Freeman, D, Juan, T, Meropol, N.J, Hecht, J.R, Berlin, J, van Cutsem, E, Reiner, M, Radinsky, R, Amado, R.G, Peeters, M

Get full text

117 Negative post-treatment 18-FDG pet scans may not predict pathologic complete response in patients with rectal cancer undergoing neoadjuvant chemoradiation by Konski, A., Sigurdson, E., Maurer, A., Hoffman, J., Haluszka, O., Cheng, J., Cohen, S.J., Engstrom, P., Watson, J., Tokar, J., Freedman, G., Meropol, N.J.

Get full text

An intravenous phase I trial of PV701, a replication-competent virus, in the treatment of patients with advanced solid cancers by Lorence, R.M., Pecora, A.L., Rizvi, N., Cohen, G.I., Meropol, N.J., Sterman, D., Marshall, J.L., O'Neil, J.D., Groene, W.S., Bamat, M.K., Rabin, H.

Get full text

30 A phase I clinical trial of HGS-ETR1, an agonist monoclonal antibody to TRAIL-R1, in patients with advanced solid tumors by Cohen, R.B., Meropol, N.J., Padavic, K.M., Fox, N.L., Corey, A., Fleming, M., Mita, M., Hill, M., Rowinsky, E.K., Tolcher, A.

Get full text

Requirement of hydrophilic amino-terminal residues for granulocyte-macrophage colony-stimulating factor bioactivity and receptor binding by MEROPOL, N. J, ALTMANN, S. W, SHANAFELT, A. B, KASTELEIN, R. A, JOHNSON, G. D, PRYSTOWSKY, M. B

Get full text